AcelRx Pharmaceuticals, Inc.
(NASDAQ : ACRX)

( )
ACRX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
HZNPHorizon Therapeutics Plc 2.40%70.555.6%$182.80m
CTLTCatalent, Inc. 2.88%97.382.1%$122.62m
VRXValeant Pharmaceuticals International, Inc. 1.93%19.5414.1%$114.98m
BHCBausch Health Cos., Inc. 1.93%19.540.0%$82.27m
JAZZJazz Pharmaceuticals Plc 1.02%143.282.4%$79.60m
GWPHGW Pharmaceuticals Plc 1.65%129.716.1%$68.89m
PRGOPerrigo Co. Plc 0.21%48.036.8%$56.45m
UTHRUnited Therapeutics Corp. 0.35%135.5414.1%$55.32m
SAGESAGE Therapeutics, Inc. -8.62%75.578.6%$53.25m
ARGXargenx SE 6.07%281.590.0%$40.59m
SAVACassava Sciences, Inc. 0.78%7.760.0%$38.85m
ICLRICON plc 1.54%191.144.2%$36.74m
AMRNAmarin Corp. Plc 0.00%4.601.5%$36.00m
BLRXBioLineRx Ltd. 3.11%2.321.8%$35.68m
ICPTIntercept Pharmaceuticals, Inc. -0.32%37.2716.8%$32.30m

Company Profile

AcelRx Pharmaceuticals, Inc. engages in the development and commercialization of therapies use in medically supervised settings. Its products include sufentanil, DZUVEO, DSUVIA ZALVISO US and ZALVISO EU. The company was founded by Thomas A. Schreck and Pamela Pierce Palmer on July 13, 2005 and is headquartered in Redwood City, CA.